Navigation Links
Molecular 'clock' could predict risk for developing breast cancer

DALLAS May 14, 2008 A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a womans risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.

In a study published in todays issue of Cancer Epidemiology Biomarkers & Prevention, scientists from UT Southwestern show that the chemical process, called methylation, is strongly correlated with breast-cancer risk and with precancerous changes in the breast cells.

The researchers determined that methylation acts as a type of biological clock, indicating how many times a cell has divided. This information could aid researchers in determining an individuals cancer risk.

The more a cell has divided, the greater the risk for cancer, said Dr. David Euhus, professor of surgical oncology. Monitoring methylation levels could give researchers a way of seeing how often cells have divided and where a woman stands on that clock. Once the clock reaches a certain hour, breast cancer is more likely to ensue.

During methylation, small molecules called methyl groups attach themselves to a gene and turn off, or silence, the gene.

Previous studies by Dr. Euhus have shown that apparently normal breast cells from women with breast cancer had increased methylation of a tumor-suppressor gene called RASSF1A.

In the current study, Dr. Euhus wanted to see if methylation of RASSF1A and other genes increased over time during the years when the ovaries are actively secreting estrogen and progesterone each month.

Dr. Euhus and his team sampled cells from 164 women women with breast cancer, women at high risk of developing breast cancer, and women with a low risk for the disease. The researchers examined methylation levels of five tumor-suppressor genes whose job is to stop tumors from developing in the breast.

A computer program developed by Dr. Euhus was used to determine the breast-cancer risk for patients in the study. Dr. Euhus has written several interactive software tools for risk measurement, which are used by major cancer centers worldwide.

His findings indicate that methylation of RASSF1A and other genes increases steadily during the years of ovarian cycling up to about age 55 suggesting that methylation is, indeed, a molecular clock recording the history of cell divisions.

Interestingly, having children, which is known to reduce breast-cancer risk if it occurs early in life, was associated with a reduction in methylation for some genes, Dr. Euhus said.

Dr. Euhus says the clock is not always marching forward, and there are ways to turn it back.

Methylation can be stopped or slowed down, said Dr. Euhus, who also directs the Mary L. Brown Breast Cancer Genetics and Risk Assessment Program at the Harold C. Simmons Comprehensive Cancer Center. We found that having a baby set the clock backward and so did getting close to menopause. Things that are known to reduce breast-cancer risk may also turn the clock backward.

A test for methylation of tumor-suppressor genes is not commercially available and Dr. Euhus says additional research is necessary to fully understand the mechanism. For example, it is not clear whether tumor-suppressor gene methylation is simply a marker of prior cell divisions, or whether it can cause increased cell division, hastening the development of breast cancer.

Dr. Euhus said medications that interfere with methylation might provide a new approach for reducing breast-cancer risk.

Even if theres a lot of methylation, I cant tell for sure if a woman is going to develop breast cancer, Dr. Euhus said. However, if I took two women from our study and one had more methylation than the other, the one with more methylation was more likely to have already had breast biopsies for benign disease, or had already been diagnosed with breast cancer.

Measuring tumor-suppressor gene methylation might not work well to predict breast-cancer risk in all women. For women with a strong family history of breast cancer, the concept wont work because those breast cancers are associated with DNA repair issues and not methylation, Dr. Euhus said.


Contact: Connie Piloto
UT Southwestern Medical Center

Related biology news :

1. Researchers discover molecular basis of a form of muscular dystrophy
2. Brown opens institute for molecular and nanoscale innovation
3. Argonne scientists develop techniques for creating molecular movies
4. Molecular basis for neurodegeneration in Ataxia telangiectasia
5. ESF conference probes waters mysterious interactions at molecular level
6. Power of molecular imaging reveals secrets of the heart
7. Computer simulations point to key molecular basis of cystic fibrosis
8. New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings
9. Molecular Biology of the Cell celebrates 25 years of publication
10. Shilatifard Lab sheds light on molecular machinery required for translation of histone crosstalk
11. How molecular muscles help cells divide
Post Your Comments:
Related Image:
Molecular 'clock' could predict risk for developing breast cancer
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/27/2015)... , Oct. 27, 2015 In the ... issues of concern for various industry verticals such as ... due to the growing demand for secure & simplified ... various ,sectors, such as hacking of bank accounts, misuse ... electronic equipment such as PC,s, laptops, and smartphones are ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
(Date:11/24/2015)... ... 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for ... Aregger to serve as Chief Operating Officer. , Having joined InSphero in ... and was promoted to Head of InSphero Diagnostics in 2014. There she ...
(Date:11/24/2015)... VILLAGE, Nev. , Nov. 24, 2015  PDL BioPharma, ... John P. McLaughlin , the company,s president and chief executive ... Jaffray Healthcare Conference next week in New York ... will occur on Tuesday, December 1, 2015 at 9:30 a.m. ... Presentations." Please connect to the website at least 15 minutes ...
(Date:11/23/2015)... Calif., Nov. 23, 2015   Ceres, Inc . ... today financial results for the fiscal year ended August ... --> --> During ... forage and feed products with a better balance of ... signed distribution agreements with several leading crop input providers ...
Breaking Biology Technology: